TR200200971T2 - Piridopirazan bileşiğinin yeni tuzları ve bunların kristalleri. - Google Patents

Piridopirazan bileşiğinin yeni tuzları ve bunların kristalleri.

Info

Publication number
TR200200971T2
TR200200971T2 TR2002/00971T TR200200971T TR200200971T2 TR 200200971 T2 TR200200971 T2 TR 200200971T2 TR 2002/00971 T TR2002/00971 T TR 2002/00971T TR 200200971 T TR200200971 T TR 200200971T TR 200200971 T2 TR200200971 T2 TR 200200971T2
Authority
TR
Turkey
Prior art keywords
crystals
new salts
pyridopyrazine
pyridopyrazine compound
compound
Prior art date
Application number
TR2002/00971T
Other languages
English (en)
Inventor
Shimazaki Norihiko
Watanabe Masaru
Ichihara Masaharu
Kawai Nobutaka
Machiya Koji
Kagara Kkoji
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Publication of TR200200971T2 publication Critical patent/TR200200971T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Genel formül (I) ile temsil edilen bir piridopirazin bilesiginin yeni bir tuzu ve bunun solvatlari ve ayrica çözünürlük ve kararlilik bakimindan mükemmel olan kristalleri.
TR2002/00971T 1998-09-29 1999-09-22 Piridopirazan bileşiğinin yeni tuzları ve bunların kristalleri. TR200200971T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27444098 1998-09-29

Publications (1)

Publication Number Publication Date
TR200200971T2 true TR200200971T2 (tr) 2002-06-21

Family

ID=17541719

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2001/00893T TR200100893T2 (tr) 1998-09-29 1999-09-22 Piridopirazin bileşiğinin yeni tuzları ve bunların kristalleri
TR2002/00971T TR200200971T2 (tr) 1998-09-29 1999-09-22 Piridopirazan bileşiğinin yeni tuzları ve bunların kristalleri.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2001/00893T TR200100893T2 (tr) 1998-09-29 1999-09-22 Piridopirazin bileşiğinin yeni tuzları ve bunların kristalleri

Country Status (13)

Country Link
EP (1) EP1118615A4 (tr)
KR (1) KR20010075287A (tr)
CN (1) CN1328555A (tr)
AU (1) AU5758199A (tr)
BR (1) BR9914399A (tr)
CA (1) CA2345362A1 (tr)
CZ (1) CZ20011164A3 (tr)
HK (1) HK1042896A1 (tr)
HU (1) HUP0103947A3 (tr)
IL (1) IL142147A0 (tr)
TR (2) TR200100893T2 (tr)
WO (1) WO2000018768A1 (tr)
ZA (1) ZA200102566B (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
TR201815573T4 (tr) * 2002-05-28 2018-11-21 Astrazeneca Ab Topikal olarak uygulanabilir farmasötik preparasyon.
BR0314364A (pt) * 2002-09-16 2005-07-19 Alcon Mfg Ltd Uso de inibidores de pde iv para tratar angiogênese
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
AU2006224619B2 (en) 2005-03-16 2012-06-07 Takeda Gmbh Taste masked dosage form containing roflumilast
CN102791152A (zh) * 2009-09-30 2012-11-21 廷塔马尔有限公司 装载袋或背心

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
WO1988001998A1 (fr) * 1986-09-16 1988-03-24 MERCK Patent Gesellschaft mit beschränkter Haftung Derives d'hydroxyindol
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives

Also Published As

Publication number Publication date
EP1118615A4 (en) 2002-02-27
HUP0103947A3 (en) 2002-06-28
CA2345362A1 (en) 2000-04-06
KR20010075287A (ko) 2001-08-09
AU5758199A (en) 2000-04-17
HK1042896A1 (zh) 2002-08-30
IL142147A0 (en) 2002-03-10
TR200100893T2 (tr) 2001-11-21
CN1328555A (zh) 2001-12-26
WO2000018768A1 (en) 2000-04-06
HUP0103947A2 (hu) 2002-04-29
EP1118615A1 (en) 2001-07-25
BR9914399A (pt) 2002-01-22
CZ20011164A3 (cs) 2001-12-12
ZA200102566B (en) 2002-07-18

Similar Documents

Publication Publication Date Title
TR200101893T2 (tr) Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler.
TR199700844T1 (tr) Pirazolil-Benzoil Türevleri.
TR200402069T4 (tr) Difenilüre türevleri ve bunların alfa 2/5-HT2c antagonisti olarak kullanılması
FR2399430A1 (fr) Chlorhydrate dihydrate de 1-(4-amino-6, 7-dimethoxy-2-quinazolinyl)-4- (2-tetrahydrofuroyl)piperazine, et son utilisation comme agents antihypertensif
TR200400857T4 (tr) Yeni galantamın türevleri ve analogları
DK0787131T3 (da) Benzensulfonamidderivater som bradykininantagonister
DK1086096T3 (da) Benzamider med tetrahydrofuranyloxy-substituenter som inhibitorer af phosphodiesterase 4
DE69812634D1 (de) Metalloproteinase-inhibitoren
AP2002002554A0 (en) Ox (ADI) azolyl-hydroxamic acids useful as procollagen C- proteinase inhibitors.
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
TR199900590T2 (tr) Kappa agonistleri olarak pirolidinil ve pirolinil etilamin bilesimleri.
DE59108770D1 (de) Fluorverbindungen als Aromatase-Inhibitoren
ATE374189T1 (de) Phthalazinon-derivate als pde 4 hemmer
TR200101654T2 (tr) Vitronektin resept”r antagonistleri
TR199802552T2 (tr) 5-HT-2C Reseptör karsitlari olarak faydali indolin türevleri.
TR200100133T2 (tr) FKBP İnhibitörleri
ES8705421A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
CO5180536A1 (es) Inhibidores de proteasas catepsina
EP1118615A4 (en) PYRIDOPYRAZINE DERIVATIVES SALTS AND CRYSTALS THEREOF
TR200402754T4 (tr) Yeni benzosultam oksazolidinon antibakteriyel maddeler.
DK0782574T3 (da) Bicycliske carboxiamider som 5-HT1A-receptorligander
TR199901535A2 (tr) Siklooksigenaz önleyicisi.
TR200102159T2 (tr) Matriks metaloproteinazlarını önleyen ters hidroksamatlar.
TR200002749T2 (tr) Antibiyotikler olarak siklik aminoguanidin substitüentlerine sahip sefalosporinler.
ES8504754A1 (es) Procedimiento para preparar la n-(3-trifluorometil fenil)-n-propargil-piperazina.